Johnson
J’s study
The vaccine uses a weakened bloodless virus, called AD26, to supply the genetic layer of the COVID-19 virus to the body’s intelligent immune cells, which then process the viral layer to exercise the immune formula to recognize and destroy any similar incoming viruses. in hamster and monkey studies, the vaccine has produced enough immune responses that can simply neutralize the virus in the lab, and initial tests on other people who in mid-July have produced equally encouraging results, which Stoffels says the company will release in the future. the next few weeks.
J coronavirus vaccine
As with other complex trials, this review will be supervised by the same Data Security Oversight Committee, which will analyze knowledge for signs of protection and symptoms of efficacy or futility.
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, who supports the trial, said the timing of the effects of the J
Something that can save J time
However, Dr. Francis Collins, director of the National Institutes of Health, said at the briefing: “People may have heard the term distortion speed and may be a little nervous that this means that things are going to rush and that changes are going to be cut in protection and efficiency. I need to assure [everyone] that this probably won’t happen. I doubt that many vaccine trials of this magnitude have ever been subjected to the rigour with which these trials are evaluated.